Imiquimod Cream Offers Alternative to Surgery for Vulvar Lesions Imiquimod Cream Offers Alternative to Surgery for Vulvar Lesions
Topical imiquimod offers an alternative to surgery for women with HPV-related precancerous lesions, concludes the first head-to-head randomized trial of the two approaches.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 17, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Which CRC Regimens Are More Likely to Harm Kidneys? Which CRC Regimens Are More Likely to Harm Kidneys?
After analyzing various treatments for metastatic colorectal cancer (CRC), researchers zeroed in on FOLFIRI  + bevacizumab. The study was published as a preprint and has not yet been peer reviewed.First Look (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 17, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Most Men With Low-Risk Prostate Tumors Now Forgoing Treatment Most Men With Low-Risk Prostate Tumors Now Forgoing Treatment
Acceptance of active surveillance for low-risk prostate cancer hit a record high in 2021, although the US still lags internationally, new figures showed.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 15, 2022 Category: Cancer & Oncology Tags: Urology News Source Type: news

Stroke in the Young: Cancer in Disguise? Stroke in the Young: Cancer in Disguise?
Young stroke patients have an increased risk of being diagnosed with a new cancer in the years following their stroke, a new study shows.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 13, 2022 Category: Cancer & Oncology Tags: Cardiology News Source Type: news

Myositis Guidelines Aim to Standardize Adult and Pediatric Care Myositis Guidelines Aim to Standardize Adult and Pediatric Care
These are the first guidelines on how to manage adult and pediatric patients with idiopathic inflammatory myopathies.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 13, 2022 Category: Cancer & Oncology Tags: Rheumatology News Source Type: news

Cancer and COVID: What Can Increase Risk of Dying? Cancer and COVID: What Can Increase Risk of Dying?
A large meta-analysis suggests that younger age and lung and blood cancers, as well as treatment with chemotherapy, raise the risk for death from COVID-19.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 13, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Patient Attitudes Toward AI in Healthcare: It Depends Patient Attitudes Toward AI in Healthcare: It Depends
A new survey looks at what patients think about AI playing a role in their healthcare diagnosis and management.WebMD Health News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 13, 2022 Category: Cancer & Oncology Tags: Internal Medicine News Source Type: news

Risk of Dying From New Cancer Higher in Young Cancer Survivors Risk of Dying From New Cancer Higher in Young Cancer Survivors
Adolescent and young adult cancer survivors are at an increased risk of developing and dying from a second primary cancer, highlighting the critical role of surveillance and survivorship care.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 12, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Attending ASCO in Person This Year? Remember These 14 Tips Attending ASCO in Person This Year? Remember These 14 Tips
Bishal Gyawali, MD, PhD, provides guidance on how to get the most out of the upcoming ASCO meeting.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 12, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Quitting Smoking Even After Lung Cancer Diagnosis Worth Doing Quitting Smoking Even After Lung Cancer Diagnosis Worth Doing
Accumulating data show that patients who quit smoking at or around the time they are diagnosed with lung cancer live longer than those who continue to smoke.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 12, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Early-Onset Colon Cancer Projected to Double by 2030 Early-Onset Colon Cancer Projected to Double by 2030
“We’re seeing a lot of younger people with this disease. It’s rather alarming,” says the author of a review that predicts further increases.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 12, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Head and Neck Cancer Patients Call for Improvements in Care Head and Neck Cancer Patients Call for Improvements in Care
Patients with head and neck cancer have the highest rates of emergency department use and hospitalization during treatment, and also the highest rates of psychological distress.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 12, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Study Hints at a Mechanism Behind Aggressive Melanoma Study Hints at a Mechanism Behind Aggressive Melanoma
A mutation in a gene involved in chromatin remodeling is associated with aggressive melanoma, suggest new data from preclinical research.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 11, 2022 Category: Cancer & Oncology Tags: Dermatology News Source Type: news

ED Visits, Readmissions Common After CAR T Therapy ED Visits, Readmissions Common After CAR T Therapy
Toxicities associated with CAR T-cell therapy typically emerge in the first month after treatment, a new analysis suggests.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 11, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Uninformed Breast Cancer Patients Are Making Treatment Decisions Uninformed Breast Cancer Patients Are Making Treatment Decisions
Women with ductal carcinoma in situ (DCIS) are generally uninformed about their diagnosis and are making uninformed treatment decisions, concludes a Dutch study.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 11, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news